Funding adult stem cell research rather than ESCR is not just good ethics, it's also good science...and good business. From an Investor's Business Daily editorial:
Five years after a budget-busting $3 billion was allocated to embryonic stem cell research [through Prop 71], there have been no cures, no therapies and little progress....
Supporters of the California Stem Cell Research and Cures Initiative, passed in 2004, held out hopes of imminent medical miracles that were being held up only by President Bush's policy of not allowing federal funding of embryonic stem cell research (ESCR) beyond existing stem cell lines and which involved the destruction of embryos created for that purpose.
Five years later, ESCR has failed to deliver and backers of Prop 71 are admitting failure. The California Institute for Regenerative Medicine, the state agency created to, as some have put it, restore science to its rightful place, is diverting funds from ESCR to research that has produced actual therapies and treatments: adult stem cell research. It not only has treated real people with real results; it also does not come with the moral baggage ESCR does.
Everyone could have been saved a lot of money and trouble if those who were pushing so hard for ESCR had spent less time calling the opposition names and more time engaging their arguments. The editorial has it exactly right:
It is ESCR researchers who have politicized science and stood in the way of real progress. We are pleased to see California researchers beginning to put science in its rightful place.